Publication Cover
AIDS Care
Psychological and Socio-medical Aspects of AIDS/HIV
Volume 19, 2007 - Issue 2
55
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

Appropriateness of antiretroviral therapy in clients of an HIV/AIDS case management organization

, &
Pages 273-281 | Published online: 11 Jan 2007

References

  • Andersen , R. , Bozzette , S. , Shapiro , M. , St Clair , P. , Morton , S. Crystal , S. 2000 . Access of vulnerable groups to antiretroviral therapy among persons in care for HIV disease in the United States . Health Services Research , 35 : 389 – 16 .
  • Anderson , K. H. and Mitchell , J. M. 2000 . Differential access in the receipt of antiretroviral drugs for the treatment of AIDS and its implications for survival . Archives of Internal Medicine , 160 : 3114 – 20 .
  • Bassetti , S. , Battegay , M. , Furrer , H. , Rickenbach , M. , Flepp , M. Kaiser , L. 1999 . Why is highly active antiretroviral therapy (HAART) not prescribed or discontinued? . JAIDS , 21 : 114 – 19 .
  • Carpenter , C.C.J. , Fischl , M.A. , Hammer , S.M. , Hirsch , M.S. , Jacobsen , D.M. Katzenstein , D.A. 1998 . Antiretroviral therapy for HIV infection in 1998: Updated recommendations of the International AIDS Society – USA Panel . Journal of the American Medical Association , 280 : 78 – 86 .
  • Celentano , D. D. , Galai , N. , Sethi , A. K. , Shah , N. G. , Strathdee , S. A. Vlahov , D. 2001 . Time to initiating highly active antiretroviral therapy among HIV-infected injection drug users . AIDS , 15 : 1707 – 15 .
  • Centers for Disease Control (1987) . Public Health Service guidelines for counseling and antibody testing to prevent HIV infection and AIDS . Morbidity and Mortality Weekly Report , 36 , 509 – 15 .
  • Centers for Disease Control (1992) . 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults . Morbidity and Mortality Weekly Report , 41 (RR-17) , 1 – 13 .
  • Centers for Disease Control (1998a) . Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents . Morbidity and Mortality Weekly Report , 47 (RR-5) , 1 – 82 .
  • Centers for Disease Control (1998b) . Summary of notifiable diseases, United States, 1998 . Morbidity and Mortality Weekly Report , 47 (53) , 1 – 93 .
  • Centers for Disease Control (1999) . HIV/AIDS Surveillance Report ( Vol. 11 , pp. 1 – 42 ). Atlanta , , Georgia : US Department of Health and Human Services, Centers for Disease Control .
  • Cook , J.A. , Cohen , M.H. , Grey , D. , Kirstein , L. , Burke , J. Anastos , K. 2002 . Use of highly active antiretroviral therapy in a cohort of HIV-seropositive women . Am J Public Health , 92 : 82 – 87 .
  • Crystal , S. , Sambamoorthi , U. , Moynihan , P. and McSpiritt , E. 2001 . Initiation and continuation of newer antiretroviral treatments among medicaid recipients with AIDS . Journal of General Internal Medicine , 16 : 850 – 859 .
  • Cunningham , W.E. , Andersen , R.M. , Katz , M.H. , Stein , M.D. , Turner , B.J. Crystal , S. 1999 . The impact of competing subsistence needs and barriers on access to medical care for persons with human immunodeficiency virus receiving care in the United States . Medical Care , 37 : 1270 – 81 .
  • Cunningham , W.E. , Markson , L.E. , Andersen , R.M. , Crystal , S.H. , Fleishman , J.A. Golin , C. 2000 . Prevalence and predictors of highly active antiretroviral therapy use in patients with HIV infection in the united states . Journal of Acquired Immune Deficiency Syndromes , 25 : 115 – 23 .
  • Cunningham , W.E. , Rana , H.M. , Shapiro , M.F. and Hays , R.D. 1997 . Reliability and validity of self-report CD4 counts in persons hospitalized with HIV disease . Journal of Clinical Epidemiology , 50 : 829 – 35 .
  • Detels , R. , Munoz , A. , McFarlane , G. , Kingsley , L.A. , Margolick , J.B. Giorgi , J. 1998 . Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration . Journal of the American Medical Association , 280 : 1497 – 1503 .
  • Fairfield , K.M. , Libman , H. , Davis , R.B. , Eisenberg , D.M. and Phillips , R.S. 1999 . Delays in protease inhibitor use in clinical practice . Journal of General Internal Medicine , 14 : 395 – 401 .
  • Fauci , A.S. , Bartlett , J.G. , Goosby , E.P. , Smith , M.D. , & Panel on Clinical Practices for Treatment of HIV Infection . (1999) . Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents . Retrieved May 5, 1999, 1999, from http://www.thebody.com/hivatis/agents/agents02.html
  • Gebo , K.A. , Fleishman , J.A. , Conviser , R. , Reilly , E.D. , Korthuis , P.T. Moore , R.D. 2005 . Racial and gender disparities in receipt of highly active antiretroviral therapy persist in a multistate sample of HIV patients in 2001 . Journal of Acquired Immune Deficiency Syndromes , 38 : 96 – 103 .
  • Giordano , T.P. , White , A.C. , Sajja , P. , Graviss , E.A. , Arduino , R.C. Adu-Oppong , A. 2003 . Factors associated with the use of highly active antiretroviral therapy in patients newly entering care in an urban clinic . Journal of Acquired Immune Deficiency Syndromes , 32 : 399 – 405 .
  • Goldstein , R.B. , Rotheram-Borus , M.J. , Johnson , M.O. , Weinhardt , L.S. , Remien , R.H. Lightfoot , M. 2005 . Insurance coverage, usual source of care, and receipt of clinically indicated care for comorbid conditions among adults living with human immunodeficiency virus . Medical Care , 43 : 401 – 10 .
  • Hsu , L.C. , Vittinghoff , E. , Katz , M.H. and Schwarcz , S.K. 2001 . Predictors of use of highly active antiretroviral therapy (HAART) among persons with AIDS in San Francisco, 1996–1999 . Journal of Acquired Immune Deficiency Syndromes , 28 : 345 – 50 .
  • Kaplan , S.H. , Gandek , B. , Greenfield , S. , Rogers , W. and Ware , J.E. 1995 . Patient and visit characteristics related to physicians' participatory decision-making style: Results from the Medical Outcomes Study . Medical Care , 33 : 1176 – 87 .
  • Keruly , J.C. , Conviser , R. and Moore , R.D. 2002 . Association of medical insurance and other factors with receipt of antiretroviral therapy . American Journal of Public Health , 92 : 852 – 57 .
  • King , R.W. , Klabe , R.M. , Reid , C.D. , & Erickson-Viitanen , S.K. (2002) . Potency of nonnucleoside reverse transcriptase inhibitors (NNRTIs) used in combination with other human immunodeficiency virus NNRTIs, NRTIs, or protease inhibitors . Antimicrobial Agents and Chemotherapy , 46 (6) , 1640 – 1646 .
  • Kitahata , M.M. , Van Rompaey , S.E. , Dillingham , P.W. , Koepsell , T.D. , Deyo , R.A. Dodge , W. 2003 . Primary care delivery is associated with greater physician experience and improved survival among persons with AIDS . Journal of General Internal Medicine , 18 : 95 – 103 .
  • Kitahata , M.M. , Van Rompaey , S.E. and Shields , A.W. 2000 . Physician experience in the care of HIV-infected persons is associated with earlier adoption of new antiretroviral therapy . Journal of Acquired Immune Deficiency Syndromes , 24 : 106 – 14 .
  • Kollmann , C. , Tremblay , C. , Giguel , F. , Chou , T.C. and Hirsch , M.S. 2001 . In vitro anti-HIV-1 synergy between non-nucleoside reverse transcriptase inhibitors nevirapine and efavirenz . Antiviral Therapy , 6 : 143 – 44 .
  • Kurdek , L.A. and Schmitt , J.P. 1987 . Perceived emotional support from family and friends in members of homosexual, married, and heterosexual cohabiting couples . Journal of Homosexuality , 14 : 57 – 68 .
  • Kuritzkes , D.R. , Marschner , I. , Johnson , V.A. , Bassett , R. , Eron , J.J. Fischl , M.A. 1999 . Lamivudine in combination with zidovudine, stavudine, or didanosine in patients with HIV-1 infection: A randomized, double-blind, placebo-controlled trial . AIDS , 13 : 685 – 94 .
  • Maisels , L. , Steinberg , J. and Tobias , C. 2001 . An investigation of why eligible patients do not receive HAART . AIDS Patient Care & STDs , 15 : 185 – 91 .
  • Mocroft , A. , Gill , M.J. , Davidson , W. and Phillips , A.N. 2000 . Are there gender differences in starting protease inhibitors, HAART, and disease progression despite equal access to care? . Journal of Acquired Immune Deficiency Syndromes , 24 : 475 – 82 .
  • Mocroft , A. , Madge , S. , Johnson , A.M. , Lazzarin , A. , Clumeck , N. Goebel , F.-D. 1999 . A comparison of exposure groups in the Euro SIDA study: Starting highly active antiretroviral therapy (HAART), response to HAART, and survival . JAIDS , 22 : 369 – 78 .
  • Murri , R. , Fantoni , M. , Del Borgo , C. , Izzi , I. , Visona , R. Suter , F. 1999 . Intravenous drug use, relationship with providers, and stage of HIV disease influence the prescription rates of protease inhibitors . Journal of Acquired Immune Deficiency Syndromes , 22 : 461 – 66 .
  • Pallela , F.J. , Delaney , K.M. , Moorman , A.C. , Loveless , M.O. , Fuhrer , J. Satten , G.A. 1998 . Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection . New England Journal of Medicine , 338 : 853 – 60 .
  • Pujol , G. ( 2006 , January/February 2006 ). HAART at 10 . Retrieved July 11, 2006, 2006, from http://www.thebody.com/asp/janfeb06/haart10.html
  • Sackoff , J.E. , McFarland , J.W. and Shin , S.S. 2000 . Trends in prescriptions for highly active antiretroviral therapy in four New York City HIV clinics . Journal of Acquired Immune Deficiency Syndromes , 23 : 178 – 83 .
  • Shapiro , M.F. , Morton , S.C. , McCaffrey , D.F. , J.W. , S. , Fleishman , J.A. , & Perlman , J.F. , et al. (1999) . Variations in the care of HIV-infected adults in the United States: Results from the HIV Cost and Services Utilization Study . JAMA , 281 (24) , 2305 – 15 .
  • Shapiro , M.F. , Morton , S.C. , McCaffrey , D.F. , Senterfitt , J.W. , Fleishman , J.A. Perlman , J.F. 1999 . Variations in the care of HIV-infected adults in the United States: Results from the HIV Cost and Services Utilization Study . Journal of the American Medical Association , 281 : 2305 – 15 .
  • Shelton , R.C. , Golin , C.E. , Smith , S.R. , Eng , E. and Kaplan , A. 2006 . Role of the HIV/AIDS case manager: Analysis of a case management adherence training and coordination program in North Carolina . AIDS Patient Care & STDs , 20 : 193 – 204 .
  • Strathdee , S.A. , Palepu , A. , Cornelisse , P.G.A. , Yip , B. , O'Shaughnessy , M.V. Montaner , J.S.G. 1998 . Barriers to use of free antiretroviral therapy in injection drug users . JAMA , 280 : 547 – 49 .
  • Turner , B.J. , Zhang , D. , Laine , C. , Pomerantz , R.J. , Cosler , L. and Hauck , W.W. 2001 . Association of provider and patient characteristics with HIV-infected women's antiretroviral therapy regimen . Journal of Acquired Immune Deficiency Syndromes , 27 : 20 – 29 .
  • Valverde , E.E. , Waldrop-Valverde , D. , Anderson-Mahoney , P. , Loughlin , A.M. , Del Rio , C. Metsch , L. 2006 . System and patient barriers to appropriate HIV care for disadvantaged populations: The HIV medical care provider perspective . Journal of the Association of Nurses AIDS Care , 17 : 18 – 28 .
  • Vittinghoff , E. , Scheer , S. , O'Malley , P. , Colfax , G. , Holmberg , S.D. , & SP , B. (1999) . Combination antiretroviral therapy and recent declines in AIDS incidence and mortality . Journal of Infectious Diseases , 179 (3) , 717 – 20 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.